Dove

Manufacturer
Conopco, Inc. d/b/a/ Unilever
Effective date
2022-12-07
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 23:52:08

Label at a glance#

ProductDove Dermacare Scalp Coconut Hydration Anti-Dandruff Conditioner
Active ingredientPYRITHIONE ZINC
Label structure10 sections

Dosage and administration

For best results use at least twice per week or as directed by a doctor. Massage into scalp and hair. Rinse.

Label contents#

Full prescribing information#

DOVE DERMACARE SCALP COCONUT HYDRATION ANTI-DANDRUFF CONDITIONER - pyrithione zinc liquid

DESCRIPTION SECTION

Dove Dermacare Scalp Coconut Hydration Anti-Dandruff Conditioner

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient
Pyrithione Zinc (0.5%)

Purpose

OTC - PURPOSE SECTION

Anti-dandruff

Use

INDICATIONS & USAGE SECTION

• Helps prevent and control recurrence of itching and flaking associated with dandruff.

Warning

WARNINGS SECTION

• For external use only
• When using this product: Avoid contact with eyes. If contact occurs, rinse eyes thoroughtly with water.
• Stop use and ask a doctor if: Condition worsens or does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

• Keep this and all drugs out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For best results use at least twice per week or as directed by a doctor. Massage into scalp and hair. Rinse.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water(Aqua), Cetearyl Alcohol, Cyclopentasiloxne, Stearamidopropyl Dimethylamine, Dimethiconol, Behentrimonium Chloride, Cocos Nucifera(Coconut)Oil, Citrus Aurantifolia (Lime) Juice, Tocopheryl Acetate, Panthenol, Fragrance(Parfum), Dipropylene Glycol, Lactic Acid, DMDM Hydantoin, Zinc Sulfate, Sodium Chloride, TEA-Dodecylbenzenesulfonate, Butylene Glycol, Iodopropynyl Butylcarbamate, PEG-150 Distearate.

Questions?

OTC - QUESTIONS SECTION

Call 1-800-761-3683

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DoveCoconutHydrationAntiDandruffCDDoveCoconutHydrationAntiDandruffCD

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1043014zinc pyrithione 0.5 % Medicated ConditionerPSN3
1043014zinc pyrithione 5 MG/ML Medicated ShampooSCD3
1043014zinc pyrithione 0.5 % Medicated ShampooSY3

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64942-1618-1DoveDermacare Scalp Coconut Hydration Anti-Dandruff Conditioner355 mL in 1 CONTAINERLIQUID3553

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64942-1618DOVE DERMACARE SCALP COCONUT HYDRATION ANTI-DANDRUFF CONDITIONER (PYRITHIONE ZINC) LIQUID [CONOPCO, INC. D/B/A/ UNILEVER]3Legacy NDC, 1 package rows20221208_780a2b5d-e81e-c94b-e053-2991aa0a31a5.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64942-161864942-1618-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ef3f5d8a-441f-28ac-e053-2995a90ab198780a2b5d-e81e-c94b-e053-2991aa0a31a52022-12-07WarningsExact identifier
spl id: ef3f5d8a-441f-28ac-e053-2995a90ab198
spl set id: 780a2b5d-e81e-c94b-e053-2991aa0a31a5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.